Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Healthtrust
McKinsey
UBS
Boehringer Ingelheim
Citi

Generated: August 21, 2019

DrugPatentWatch Database Preview

Patent: 9,492,414

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,492,414
Title:Treatment and diagnosis of colon cancer
Abstract: The present invention discloses novel agents and methods for diagnosis and treatment of colon cancer. Also disclosed are related arrays, kits, and screening methods.
Inventor(s): Tavazoie; Sohail (New York, NY), Loo; Jia M. (New York, NY)
Assignee: The Rockefeller University (New York, NY)
Application Number:14/706,038
Patent Claims:see list of patent claims

Details for Patent 9,492,414

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Sanofi Aventis Us ZALTRAP ziv-aflibercept INJECTABLE; INJECTION 125418 001 2012-08-03   Try a Free Trial The Rockefeller University (New York, NY) 2033-10-31 RX search
Genentech AVASTIN bevacizumab VIAL; INTRAVENOUS 125085 002 2004-02-26   Try a Free Trial The Rockefeller University (New York, NY) 2033-10-31 RX search
Genentech AVASTIN bevacizumab VIAL; INTRAVENOUS 125085 001 2004-02-26   Try a Free Trial The Rockefeller University (New York, NY) 2033-10-31 RX search
Imclone ERBITUX cetuximab VIAL; INTRAVENOUS 125084 001 2004-06-18   Try a Free Trial The Rockefeller University (New York, NY) 2033-10-31 RX Orphan search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

International Patent Family for US Patent 9,492,414

Country Patent Number Publication Date
World Intellectual Property Organization (WIPO) 2014071067 Jul 03, 2014
World Intellectual Property Organization (WIPO) 2014071067 May 08, 2014
United States of America 10172817 Jan 08, 2019
United States of America 2014378534 Dec 25, 2014
United States of America 2015335601 Nov 26, 2015
United States of America 2017296497 Oct 19, 2017
>Country >Patent Number >Publication Date

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Mallinckrodt
Queensland Health
Federal Trade Commission
Merck
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.